{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=End+Stage+Renal+Disease+and+Kidney+Transplantation&page=2", "query": { "condition": "End Stage Renal Disease and Kidney Transplantation", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=End+Stage+Renal+Disease+and+Kidney+Transplantation&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-05-22T05:08:15.467Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01950819", "title": "Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "End Stage Renal Disease (ESRD)", "Chronic Kidney Disease (CKD)", "Hemodialysis", "Renal Replacement Therapy", "Renal Transplantation" ], "interventions": [ { "name": "Induction therapy", "type": "BIOLOGICAL" }, { "name": "Corticosteroids", "type": "DRUG" }, { "name": "EVR+rCNI", "type": "DRUG" }, { "name": "MPA+sCNI", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2037, "start_date": "2013-12-03", "completion_date": "2018-01-17", "has_results": true, "last_update_posted_date": "2019-01-30", "last_synced_at": "2026-05-22T05:08:15.467Z", "location_count": 40, "location_summary": "Birmingham, Alabama • Loma Linda, California • Los Angeles, California + 32 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Loma Linda", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01950819" }, { "nct_id": "NCT05879302", "title": "Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "End Stage Renal Disease", "End-Stage Kidney Disease", "Kidney Transplantation", "Esrd" ], "interventions": [ { "name": "Kidney Offer Shared Decision Making", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Hennepin Healthcare Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2024-04-03", "completion_date": "2026-02-17", "has_results": false, "last_update_posted_date": "2026-04-13", "last_synced_at": "2026-05-22T05:08:15.467Z", "location_count": 2, "location_summary": "Minneapolis, Minnesota • Rochester, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05879302" }, { "nct_id": "NCT03194321", "title": "Trial to Evaluate Safety and Tolerability of Tacrolimus Extended-Release (Astagraf XL) in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "End Stage Renal Disease" ], "interventions": [ { "name": "Tacrolimus Extended-Release Oral Capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cedars-Sinai Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2017-09-11", "completion_date": "2020-10-27", "has_results": true, "last_update_posted_date": "2022-01-19", "last_synced_at": "2026-05-22T05:08:15.467Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03194321" }, { "nct_id": "NCT02268682", "title": "Explore Transplant at Home: Improving Low-Income ESRD Patients' Transplant Knowledge", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "End Stage Renal Disease" ], "interventions": [ { "name": "Patient-Guided", "type": "OTHER" }, { "name": "Educator-Guided", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "The Methodist Hospital Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "18 Years to 74 Years" }, "enrollment_count": 558, "start_date": "2014-07", "completion_date": "2016-08", "has_results": false, "last_update_posted_date": "2023-12-28", "last_synced_at": "2026-05-22T05:08:15.467Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02268682" }, { "nct_id": "NCT00023231", "title": "Pediatric Kidney Transplant Without Calcineurin Inhibitors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "End-Stage Renal Disease" ], "interventions": [ { "name": "Daclizumab", "type": "DRUG" }, { "name": "Methylprednisolone/prednisone", "type": "DRUG" }, { "name": "Mycophenolate mofetil", "type": "DRUG" }, { "name": "Sirolimus", "type": "DRUG" }, { "name": "Bactrim", "type": "DRUG" }, { "name": "Ganciclovir", "type": "DRUG" }, { "name": "Lipitor", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "21 Years", "sex": "ALL", "summary": "Up to 21 Years" }, "enrollment_count": 35, "start_date": "2001-02", "completion_date": "2006-08", "has_results": false, "last_update_posted_date": "2016-10-21", "last_synced_at": "2026-05-22T05:08:15.467Z", "location_count": 1, "location_summary": "Rockville, Maryland", "locations": [ { "city": "Rockville", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00023231" }, { "nct_id": "NCT05411744", "title": "One-month Latent Tuberculosis Treatment for Renal Transplant Candidates", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Latent Tuberculosis", "End Stage Renal Disease", "Renal Transplant Candidate for Right Kidney", "Renal Transplant Candidate for Left Kidney" ], "interventions": [ { "name": "1 month Rifapentine, Isoniazid and Vitamin B6", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rutgers, The State University of New Jersey", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 25, "start_date": "2022-07-01", "completion_date": "2029-06-30", "has_results": false, "last_update_posted_date": "2026-01-21", "last_synced_at": "2026-05-22T05:08:15.467Z", "location_count": 1, "location_summary": "New Brunswick, New Jersey", "locations": [ { "city": "New Brunswick", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05411744" }, { "nct_id": "NCT02224144", "title": "Bone Mass and Strength After Kidney Transplantation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "End Stage Renal Disease", "Kidney Transplantation", "Bone Loss", "Fractures", "Vascular Calcifications" ], "interventions": [ { "name": "Vitamin D3", "type": "DRUG" }, { "name": "Calcitriol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 61, "start_date": "2014-08-18", "completion_date": "2016-10-12", "has_results": true, "last_update_posted_date": "2025-03-07", "last_synced_at": "2026-05-22T05:08:15.467Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02224144" }, { "nct_id": "NCT01178216", "title": "Use of Immune Globulin Plus Rituximab for Desensitization in Highly HLA Sensitized Patients Awaiting Deceased Donor Kidney Transplantation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "End Stage Renal Disease" ], "interventions": [ { "name": "Rituxan", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Stanley Jordan, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 41, "start_date": "2013-09", "completion_date": "2017-07-28", "has_results": true, "last_update_posted_date": "2018-10-26", "last_synced_at": "2026-05-22T05:08:15.467Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01178216" }, { "nct_id": "NCT05525507", "title": "Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "End Stage Kidney Disease", "Immunological Tolerance", "Kidney Transplant Failure and Rejection", "Chronic Kidney Diseases" ], "interventions": [ { "name": "Conditioning and Stem cell infusion", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "University of California, Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2022-12-21", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2025-11-26", "last_synced_at": "2026-05-22T05:08:15.467Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05525507" }, { "nct_id": "NCT00560014", "title": "Nutrient Levels Alter Transplant Outcome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Renal Disease" ], "interventions": [ { "name": "Arginine and canola oil", "type": "DIETARY_SUPPLEMENT" }, { "name": "Coromega and Arginine", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "University of Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 54, "start_date": "1997-09", "completion_date": "2005-05", "has_results": false, "last_update_posted_date": "2007-11-19", "last_synced_at": "2026-05-22T05:08:15.467Z", "location_count": 2, "location_summary": "Washington D.C., District of Columbia • Durham, North Carolina", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00560014" } ] }